Assessing Aveanna Healthcare Holdings (AVAH) Valuation After Its Strong Multi‑Year Share Price Rebound

Aveanna Healthcare Holdings (AVAH) has quietly delivered a strong run over the past year, nearly doubling in value, as investors warm to its steady revenue growth and improving profitability in home based care.

See our latest analysis for Aveanna Healthcare Holdings.

That strength is showing up clearly in the tape, with the share price now at $8.93 and a near doubling year to date on a share price return basis. The three year total shareholder return of over 1,000 percent signals powerful, long running momentum as investors reassess both the company’s growth runway and its risk profile.

If this kind of home based care rebound has your attention, it could be worth seeing which other names are setting up in the same space through healthcare stocks.

With Aveanna now trading near analysts’ targets after a dramatic three year rerating, the key question is whether robust earnings momentum still leaves room for upside, or if the market has already priced in the next leg of growth?

Most Popular Narrative Narrative: 15.4% Undervalued

Compared with Aveanna Healthcare Holdings' last close at $8.93, the most followed narrative points to a higher fair value anchored in improving earnings power.

Consensus Analyst Price Target has risen slightly from $10.17 to $10.55 per share.

Revenue Growth is now projected at 7.81 percent, up from the previous estimate of 7.39 percent.

Read the complete narrative.

Want to see what sits behind that higher revenue run rate, and why margin forecasts keep edging up as the discount rate drifts lower? The narrative unpacks a carefully layered earnings ramp, share count assumptions, and a future earnings multiple that could reshape how this home care player is priced. Curious which moving part really makes the valuation work, and how sensitive the fair value is to it? Read on to see the full blueprint.

Result: Fair Value of $10.55 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, sustained wage inflation or tighter Medicaid and Medicare reimbursement could quickly pressure margins and undercut the earnings ramp embedded in current expectations.

Find out about the key risks to this Aveanna Healthcare Holdings narrative.

Build Your Own Aveanna Healthcare Holdings Narrative

If you see the story differently or want to test your own assumptions against the numbers, you can build a custom view in minutes: Do it your way.

A great starting point for your Aveanna Healthcare Holdings research is our analysis highlighting 3 key rewards and 2 important warning signs that could impact your investment decision.

Looking for more investment ideas?

Before you move on, lock in your next opportunity by using the Simply Wall St screener to uncover focused, data driven ideas that others may overlook.

• Capitalize on market mispricing by targeting companies flagged as compelling opportunities through these 902 undervalued stocks based on cash flows before broader sentiment catches up.
• Ride the momentum of intelligent automation by scanning for innovation focused businesses at the forefront of next generation tech with these 24 AI penny stocks.
• Strengthen your income strategy by zeroing in on reliable payouts and resilient balance sheets via these 10 dividend stocks with yields > 3%.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com